HEALTH AND PUBLIC POLICY COMMITTEE*
A safe, highly effective, licensed vaccine for the prevention of hepatitis B virus infection is available. Hepatitis B is a common and serious disease with an annual incidence in the United States of 200 000 cases. Seventy-five percent of patients with hepatitis B have mild or subclinical disease, 25% develop jaundice, 5% require hospitalization, and 0.1% die of fulminant disease; 6% to 10% of infected patients become chronic carriers. Of the 600 000 to 800 000 carriers in the United States, approximately 25% develop chronic hepatitis and approximately 4000 die of cirrhosis each year. In addition, 1% to 2% of
Learn more about subscription options.
Register Now for a free account.
HEALTH AND PUBLIC POLICY COMMITTEE*. Hepatitis B Vaccine. Ann Intern Med. 1984;100:149–150. doi: 10.7326/0003-4819-100-1-149
Download citation file:
Published: Ann Intern Med. 1984;100(1):149-150.
Gastroenterology/Hepatology, Infectious Disease, Prevention/Screening, Vaccines/Immunization, Viral Hepatitis.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only